Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for laryngeal mask insertion during general anesthesia induction
ChiCTR2200062666Phase 4Not yet recruiting
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in anesthesia induction (2 arms), sponsored by Zhuji People's Hospital of Zhejiang Province. Primary endpoints: Induction success rate of general anesthesia, Time to MOAA/S score <= 1 and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
anesthesia induction
Beyond the preview
Go deeper on ChiCTR2200062666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062666.